MedNexa Inc.

AI-POWERED MEDICAL INTELLIGENCE

Building a better future of medicine with AI

MedNexa unifies global pharmaceutical data with advanced AI to accelerate decisions across drug discovery and development. From data, we create the next value in medicine.

Explore solutionsContact us
190+
Countries & regions
50K+
Drugs analyzed
24/7
Regulatory intelligence

Connecting data and people — creating the future of medicine, together.

MedNexa Inc. provides PharmaGap®, an AI SaaS built on pharmaceutical data, and PharmaAPI, an API for pharmaceutical data integration.

PharmaGap®

PharmaGap®

AI Pharmaceutical Intelligence SaaS

Available
PharmaAPI

PharmaAPI

Pharmaceutical Data API / Platform

Upcoming

Pioneering the future of medical AI

From discovery to market access, a research-grade data foundation and AI support every step.

Global Drug Data

Cross-reference data from FDA, EMA, PMDA and other major authorities. Track approvals, indications and pricing in one place.

Regulatory Intelligence

Monitor guideline updates 24/7. Detect regulatory shifts early and feed them straight into your development strategy.

Literature AI

Analyze clinical trials, papers and labels with large language models, presenting structured, traceable evidence.

Gap Detection

Automatically surface white space across regions, indications and development stages. Quantify unmet needs.

Opportunity Scoring

Evaluate market potential, competition and regulatory risk across dimensions, ranking opportunities with a proprietary score.

Report Generation

Compile analyses into decision-ready reports, accelerating investment and business-development calls.

PharmaGapPRODUCT

AI Pharmaceutical Intelligence SaaS

PharmaGap® —Pharmaceutical Gap Analysis Platform

All the world's pharma data in a single workspace. BD, research and regulatory teams decide on the same source of truth.

  • Cross-search approval data across 190+ countries and regions
  • Fast filters by indication, INN and approval number
  • AI opportunity scores with transparent rationale
  • Research-grade UI with light & dark modes
PharmaGappharmagap.appResearch-grade SaaS
50,284
解析品目 / Drugs
1,203
規制更新 / Updates
417
機会 / Opportunities
ScoreDrugPrice
92
Lecanemab
lecanemab
¥298,000
88
Tirzepatide
tirzepatide
¥45,200
85
Donanemab
donanemab
—
79
Resmetirom
resmetirom
—
PharmaAPIapi.mednexa.ioDeveloper API
GET/v1/drugs?inn=lecanemab
{
  "inn": "lecanemab",
  "approvals": [
    { "authority": "FDA", "id": "BLA761269" },
    { "authority": "EMA", "id": "EMEA/H/C/006888" },
    { "authority": "PMDA", "id": "30500AMX00567" }
  ],
  "indications": ["Alzheimer's disease"],
  "opportunityScore": 92
}
PharmaAPIPRODUCT

Pharmaceutical Data API / Platform

PharmaAPI —Pharmaceutical Data API

MedNexa's pharmaceutical data, delivered as an API. Pull approval, regulatory, clinical and pricing data straight into your own systems and workflows.

  • Cross-query via REST / GraphQL endpoints
  • Real-time sync from FDA, EMA, PMDA and more
  • Fast queries by approval number, INN or indication
  • Webhooks push regulatory updates in real time
OUR PHILOSOPHY
From pharmaceutical data,
we create the next value in medicine.

We transform the world's fragmented pharmaceutical information into decision-ready knowledge — connecting AI with human expertise to make medical progress faster and more certain.

About